Knockoff copies of Novo’s weight loss medicine Wegovy have held back sales and put the drugmaker on the back foot in its ...

Pedersen, Stine Jacobsen and Maggie Fick COPENHAGEN (Reuters) -Investors wiped $70 billion off Novo Nordisk's market value on ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

The company now expects full-year sales growth of 8% to 14% at a constant exchange rate, down from its previous estimate of ...

Novo Nordisk stock (ticker: NVO) fell after the drugmaker unexpectedly cuts its full-year guidance, citing lower sales ...